OJBIPHY  Vol.7 No.4 , October 2017
Contribution of Myocardial Perfusion’s Tomoscintigraphy in the Management of Coronarian Disease in Senegal: About 42 Cases
The aim of the study was to evaluate the contribution to moscintigraphy of myocardial perfusion (TSMP) with 99mTc-sestamibi in the management of suspected or known coronary patients’s population. It included 42 patients with an average age of 57.02 ± 9.77 years with extremes ranging from 36 to 77 years. The pre-test probability in 38 patients was high in 7 patients (18.42%), intermediate in 29 patients (76.31%) and low in 2 patients (5.26%). Patients with a high pre-test probability had a positive scintigraphy. Among the 26 patients who underwent transthoracic ultrasound (TTU), 10 with normal kinetics on trans-thoracic ultrasound (TTU) had positive scintigraphy. For 16 patients with TTU abnormalities, 6 had negative scintigraphy and 10 had positive scintigraphy. The TSMP was positive for 28 patients (66.66%). Among these patients, 16 had pure ischemia, 57.14% (16/28), 7 pure necrosis (25%), and 5 both necrosis and ischemia. Myocardial perfusion scintigraphy remains a very contributory consideration in the management of coronary disease. This is synchronized with the electrocardiogram (ECG) and is an important diagnostic and prognostic tool for coronary artery disease. It also provides a good indication of coronary angiography.
Cite this paper: Ndong, B. , Mbaye, G. , Bathily, E. , Diop, O. , Diop, A. , Diouf, L. , Mbaye, A. , Senghor, R. , Soumboundou, M. , Djiboune, A. , Sy, P. , Badji, N. , Dia, A. , Djigo, M. , Mbodj, M. , Ndoye, O. , Diarra, M. , Kane, A. and Seck-Gassama, S. (2017) Contribution of Myocardial Perfusion’s Tomoscintigraphy in the Management of Coronarian Disease in Senegal: About 42 Cases. Open Journal of Biophysics, 7, 175-182. doi: 10.4236/ojbiphy.2017.74013.

[1]   [1]Angehrn, W. (2001) Chronic Ischemic Heart Disease. Forum Médical Suisse, 8, 1187-1191.

[2]   Ferrario, M., Cesana, G. and Vanuzzo, D. (2001) Surveillance of Ischaemic Heart Disease: Results from the Italian Monico Population. International Journal of Epidemiology, 30, 23-29.

[3]   Murray, C.J. and Lopez, A.D. (1997) Alternative Projections of Mortality and Disability by Cause 1990-2020: Global Burden of Disease Study. The Lancet, 349, 1498-1504.

[4]   Ladenheim, M.L., Pollock, B.H., Rozanski, A., Berman, D.S., Stanilof, H.M., Forrester, J.S., et al. (1986) Extent and Severity of Myocardial Hypoperfusion as Predictors of Prognosis in Patients with Suspect Coronary Artery Disease. Journal of the American College of Cardiology, 7, 464-471.

[5]   Northridge, D.B., Grand, S., Henderson, E., Ray, S., Mcmurray, J. and Dargie, H.J. (1990) A Novel Exercise Protocol Suitable for Use on a Treadmill or a Bicycle Ergometer. British Heart Journal, 64, 313-316.

[6]   Diamond, G.A. and Forrester, J.S. (1979) Analysis of Probability in the Clinical Diagnosis of Coronary Artery Disease. The New England Journal of Medicine, 300, 1350-1358.

[7]   Sanmarco, M.E., Pontius, S. and Selvester, R.H. (1980) Abnormal Blood Pressure Response and Marked Ischemic St-Segment Depression as Predictors of Severe Coronary Artery Disease. Circulation, 61, 572-578.

[8]   Depuey, E.G. (1994) How to Detect and Avoid Myocardial Perfusion SPECT Artifacts. The Journal of Nuclear Medicine, 35, 699-702.

[9]   Dunet, V., Costo, S., Sabatier, R., Grollier, G., Bouvard, G. and Agostini, D. (2010) Feasibility and Diagnostic Accuracy of a Myocardial Scintigraphy Protocol Synchronized with E.C.G in Two Hours: The Myofaste Study. Nuclear Medicine, 34, 211-218.

[10]   Jain, D., Wackers, F.J., Mattera, J., Mc Mahon, M., Sinusas, A.J. and Zaret, B.L. (1993) Biokinetics of Technetium-Tétrofosmine: Myocardial Perfusion Imaging Agent: Implications for a One-Day Imaging Protocol. The Journal of Nuclear Medicine, 34, 1254-1259.

[11]   Flamen, P., Bossuyt, A. and Franken, P.R. (1995) Technetium-99m-Tetrofosmin in Dipyridamole-Myocardial Stress SPECT Imaging: Intraindividual Comparison with Technetium-99m-Sestamibi. The Journal of Nuclear Medicine, 36, 2009-2015.

[12]   Vanzetto, G., Machecourt, J. and Fagret, D. (2000) Myocardial Perfusion Tomoscintigraphy (Mpts) and Prognostic Evaluation of Coronary Artery Disease. Review of the Acomen, 6, 114-121.

[13]   Abdenbi, K. (2002) Smoking Cessation in the Coronary. Annales de Cardiologie et d'Angéiologie, 51, 357-366.

[14]   Worker, M.J., Bernard, M., Hitzel, A., Vera, P. and Manrique, A. (2009) Evaluation of Myocardial Sideration Post-Exertion Immediately by Tomoscintigraphy with 99mtc Coupled to the ECG. Nuclear Medicine, 33, 331-337.

[15]   Manrique, A. and Marie, P.Y. (2003) Recommendations for the Performance and Interpretation of Myocardial Perfusion Tomoscintigraphy. Archives des Maladies du Coeur et des Vaisseaux, 96, 695-711.

[16]   Calizzano, A. (2007) Current Position and Future Prospects of Myocardial Perfusion Scintigraphy. Nuclear Medicine, 31, 604-609.

[17]   Levy, M. (2006) Myocardial Scintigraphy and Prognosis in Coronary Disease. MT Cardiologists, 2, 223-234.